➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Boehringer Ingelheim
Express Scripts
McKinsey
Merck

Last Updated: October 29, 2020

DrugPatentWatch Database Preview

Details for Biologics License Application: 125317

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for BLA: 125317
Tradename:RIASTAP
Applicant:Csl Behring Gmbh
Ingredient:fibrinogen human
Patents:41
Approval Date:Jan 16, 2009
Suppliers: see list1

US Patents for BLA: 125317

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Csl Behring Gmbh RIASTAP fibrinogen human INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 125317 1 2009-01-16   Start Trial The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc. (Rockville, MD) Virginia Commonwealth University (Richmond, VA) 2028-04-11 search
Csl Behring Gmbh RIASTAP fibrinogen human INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 125317 1 2009-01-16   Start Trial JAPAN BLOOD PRODUCTS ORGANIZATION (Tokyo, JP) 2033-12-27 search
Csl Behring Gmbh RIASTAP fibrinogen human INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 125317 1 2009-01-16   Start Trial Universite Paris Descartes (Paris, FR) Assistance Publique--Hopitaux De Paris (Paris, FR) Universite Paris--Sud (Orsay, FR) Universite Pierre et Marie Curie (Paris 6) (Paris, FR) Institut National De La Sante et De La Recherche Medical 2035-03-20 search
Csl Behring Gmbh RIASTAP fibrinogen human INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 125317 1 2009-01-16   Start Trial The Radiochemical Centre Limited (Amersham, EN) 1993-01-20 search
Csl Behring Gmbh RIASTAP fibrinogen human INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 125317 1 2009-01-16   Start Trial 1995-05-15 search
Csl Behring Gmbh RIASTAP fibrinogen human INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 125317 1 2009-01-16   Start Trial American Home Products Corporation (New York, NY) 1995-10-31 search
Csl Behring Gmbh RIASTAP fibrinogen human INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 125317 1 2009-01-16   Start Trial American Home Products Corp. (Del.) (New York, NY) 1995-10-31 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Harvard Business School
Boehringer Ingelheim
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.